Correlation Between Tcr2 Therapeutics and Aldeyra
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Aldeyra, you can compare the effects of market volatilities on Tcr2 Therapeutics and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Aldeyra.
Diversification Opportunities for Tcr2 Therapeutics and Aldeyra
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tcr2 and Aldeyra is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Aldeyra go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Aldeyra
Given the investment horizon of 90 days Tcr2 Therapeutics is expected to generate 0.84 times more return on investment than Aldeyra. However, Tcr2 Therapeutics is 1.19 times less risky than Aldeyra. It trades about 0.03 of its potential returns per unit of risk. Aldeyra is currently generating about 0.03 per unit of risk. If you would invest 141.00 in Tcr2 Therapeutics on August 27, 2024 and sell it today you would earn a total of 7.00 from holding Tcr2 Therapeutics or generate 4.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 18.02% |
| Values | Daily Returns |
Tcr2 Therapeutics vs. Aldeyra
Performance |
| Timeline |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aldeyra |
Tcr2 Therapeutics and Aldeyra Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tcr2 Therapeutics and Aldeyra
The main advantage of trading using opposite Tcr2 Therapeutics and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
| Aldeyra vs. Eliem Therapeutics | Aldeyra vs. HCW Biologics | Aldeyra vs. Scpharmaceuticals | Aldeyra vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |